Executive Summary
Joby Aviation declined 21.53% to $10.57 following the announcement of a significantly dilutive $1.18 billion capital raise, comprising $600 million in convertible notes and $600 million in equity at $11.35 per share. This marks the most severe single-session decline in the stock's recent history, breaking through all technical support levels and accelerating the YTD decline to -19.92%. While the capital raise substantially extends the company's runway for certification and manufacturing through 2027-2028, the 52.86 million share issuance represents material dilution that has fundamentally reset valuation expectations and triggered a re-evaluation of the investment thesis.
Key Updates
Joby Aviation experienced a precipitous 21.53% decline to $10.57 since the January 28th report, driven entirely by the January 29th announcement of an upsized concurrent public offering. The company priced $600 million in 0.75% convertible senior notes due 2032 with a conversion price of $14.19 per share (25% premium to offering price) alongside 52.86 million common shares at $11.35 per share. Combined net proceeds of approximately $1.16 billion will fund certification, manufacturing expansion, commercial operations preparation, and working capital through the critical 2026-2028 commercialization period. The offering size increased from the initially announced $1.0 billion, indicating strong institutional demand despite the dilutive impact. This represents the company's most significant capital raise since going public and provides financial flexibility to execute its manufacturing scale-up plan, including the recently announced second Ohio facility acquisition.
Current Trend
JOBY has declined 19.92% year-to-date to $10.57, with accelerating downward momentum across all timeframes: -5.12% (1-day), -24.12% (5-day), -19.92% (1-month), and -37.16% (6-month). The stock broke decisively below the $13.00-$14.00 consolidation range that had held since mid-January, establishing a new trading range in the $10.00-$11.00 area. The 5-day decline of -24.12% represents the most severe short-term correction in recent history, with the offering price of $11.35 now serving as immediate resistance. The convertible notes' $14.19 conversion price establishes a technical ceiling 34% above current levels. Trading volume surged on the offering announcement, confirming distribution and a fundamental repricing of equity value following the dilution. All moving averages have turned negative, with no immediate technical support until the $9.50-$10.00 zone.
Investment Thesis
The investment thesis centers on Joby's position as the leading U.S. eVTOL manufacturer approaching FAA certification and commercial launch in 2026, with manufacturing capacity scaling to four aircraft per month by 2027. The $1.16 billion capital raise fundamentally strengthens the company's ability to execute this timeline, eliminating near-term financing risk and providing runway through initial commercialization. However, the 52.86 million share issuance materially dilutes existing shareholders and resets valuation expectations lower. The thesis now depends on management's ability to deploy this capital efficiently toward certification milestones, manufacturing ramp, and commercial operations launch while demonstrating a clear path to revenue generation. The company's expanded 700,000 square-foot Ohio facility and FAA-qualified flight simulators indicate operational progress, but the capital raise confirms that the path to profitability remains multi-year and capital-intensive. Competitive dynamics are intensifying with Vertical Aerospace, Eve Air Mobility, and new entrants like COOLFLY all advancing toward commercialization, though Joby maintains regulatory and manufacturing advantages.
Thesis Status
The investment thesis has been significantly impaired in the near term due to the dilutive capital raise, though the long-term strategic positioning remains intact. The 21.53% decline reflects market recognition that the 52.86 million share issuance substantially increases the denominator in per-share value calculations, requiring proportionally higher future cash flows to justify previous valuations. However, the thesis is strengthened by the elimination of financing risk through 2028, allowing management to focus exclusively on execution rather than capital markets access. The convertible notes structure with a $14.19 conversion price (34% above current levels) suggests institutional investors see upside potential tied to certification and commercialization milestones. The thesis now requires evidence of manufacturing efficiency gains, FAA certification progress, and early commercial traction to validate the capital deployment. The competitive landscape has become more crowded with Eve Air Mobility securing $150 million and Vertical Aerospace advancing certification timelines, reducing Joby's first-mover advantage. Overall thesis status: NEUTRAL-TO-CAUTIOUS, pending demonstration of operational execution against the expanded capital base.
Key Drivers
The primary driver is the $1.18 billion upsized capital raise announced January 29th, comprising $600 million in convertible notes and $600 million in equity at $11.35 per share. The company will deploy approximately $576 million from equity proceeds and $582.9 million from note proceeds (after $55 million for capped call transactions) toward certification, manufacturing, and commercial operations. This follows the January 7th announcement of a second 700,000 square-foot Ohio manufacturing facility to double production capacity to four aircraft per month by 2027. The January 6th delivery of FAA-qualified flight simulators capable of training 250 pilots annually demonstrates progress toward commercial operations. Competitive pressure is mounting with Eve Air Mobility securing $150 million in debt financing and Vertical Aerospace announcing New York routes with 2028 certification targets. Industry momentum continues with JPMorgan projecting the eVTOL market to reach $1 trillion globally by 2040.
Technical Analysis
JOBY experienced a catastrophic technical breakdown, declining 21.53% to $10.57 and breaking through the $13.00-$14.00 consolidation range that had held for three weeks. The stock traded below the $11.35 offering price intraday, indicating immediate seller exhaustion, with current levels representing a 34% discount to the $14.19 convertible note conversion price. The 5-day decline of -24.12% represents the steepest correction in recent history, with volume surging 300-400% above average on the offering announcement. Key resistance now sits at $11.35 (offering price), $12.50 (50% retracement), and $14.19 (conversion price). Support exists at $10.00 (psychological level) and $9.50 (6-month lows). The relative strength index has entered oversold territory below 30, suggesting potential for a technical bounce, though momentum indicators remain firmly negative. The convertible notes create a technical ceiling at $14.19 through 2032, as conversion activity will cap upside until the company demonstrates sufficient operational progress to justify higher valuations. The stock requires stabilization above $11.00 and reclamation of $12.00 to signal technical recovery.
Bull Case
- Capital runway extended through commercialization: The $1.16 billion net proceeds eliminate financing risk through 2028, providing sufficient capital to complete FAA certification, scale manufacturing to four aircraft per month by 2027, and launch commercial operations without additional dilution requirements.
- Manufacturing capacity doubling on schedule: The 700,000 square-foot Ohio facility acquisition and capital equipment procurement positions Joby to achieve four aircraft per month production by 2027, representing a clear path to revenue generation and economies of scale in manufacturing.
- Pilot training infrastructure operational: The FAA-qualified flight simulators with capacity to train 250 pilots annually demonstrate readiness for commercial launch in 2026, addressing a critical operational requirement ahead of competitors and validating the company's timeline.
- Trillion-dollar market opportunity: JPMorgan projects the global eVTOL market will reach $1 trillion by 2040, with Joby positioned as the leading U.S. manufacturer approaching commercial operations, providing substantial long-term growth potential despite near-term dilution.
- Institutional confidence in convertible structure: The upsizing from $1.0 billion to $1.18 billion and $14.19 conversion price (34% premium) indicate sophisticated institutional investors see significant upside potential tied to certification and commercialization milestones over the 2026-2028 period.
Bear Case
- Severe dilution resets valuation floor: The 52.86 million share issuance at $11.35 represents material dilution to existing shareholders, with the 21.53% decline confirming market recognition that per-share value has been fundamentally reset lower and requires proportionally higher future cash flows to justify previous valuations.
- Intensifying competitive landscape: Eve Air Mobility secured $150 million and completed its first full-scale prototype flight, Vertical Aerospace announced New York routes with 1,500 pre-orders, and new entrants are emerging, reducing Joby's first-mover advantage and increasing commercialization risk.
- Multi-year path to profitability confirmed: The need for a $1.18 billion capital raise confirms that Joby remains multiple years away from positive cash flow, with significant execution risk around FAA certification, manufacturing ramp, and commercial operations launch before any meaningful revenue generation occurs.
- Technical breakdown signals further downside: The 24.12% five-day decline broke all support levels, with the stock trading 34% below the $14.19 convertible note conversion price, suggesting institutional investors expect limited near-term upside and potential for further correction toward $9.50-$10.00 support levels.
- Regulatory and operational execution risk: Despite progress on pilot training infrastructure and manufacturing expansion, FAA certification remains uncertain, manufacturing scale-up is unproven, and commercial operations launch faces numerous regulatory and operational hurdles that could delay revenue generation beyond 2026-2027 timelines.